GLOBAL GLUCOSE MONITORING SYSTEM MARKET FORECAST 2017-2025
KEY FINDINGS
The global glucose monitoring system market is separated into continuous glucose monitoring market (CGMS) and self-monitoring of blood glucose (SMBG) market. The CGMS market is anticipated to grow $ 13672 million by 2025. The SMBG market is estimated to grow $ 20563 million by 2025, at a CAGR of 36.72% between 2016 and 2025. The base year considered for the market study is 2016 and the forecast period is between 2017 and 2025. The (CGM) continuous glucose monitoring device is system practiced to measure glucose levels in the interstitial fluid that commence between the skin cells and display in the monitor. (SMBG) Self-monitoring of blood glucose is to supervise glucose level.
MARKET INSIGHTS
The continuous glucose monitoring system and self-monitoring blood glucose is segmented into component type, application, and geography. The CGMS market by component type is segmented into sensors, transmitters, receivers, and insulin pump. The application segmented of CGMS is further segmented into diagnostics and clinics, hospitals, and home settings. The SMBG market by the component is segmented into test strips, glucose meter, and others. The application segmented of SMBG is further bifurcated into home settings, clinics, and hospitals. The geography market is segmented into North America, Europe, Asia-Pacific, Latin America and rest of the world. Rise in Diabetic Population, growth in Healthcare Expenditure, high Focus on Research and Development, Technology Integration, Increase in the CGMS Affordability, and less Price of Technology are the major drivers for the Glucose monitoring market.
REGIONAL INSIGHTS
The CGMS and SMBG market in North America is anticipated to hold the largest share by 2025 whereas in both CGMS and SMBG market Asia Pacific is expected to be the fastest growing region with a CAGR of 48.72% and 15.82% during the forecast period. North America is a highly developed market for CGMS and SMBG with over 3 million of Type 1 Diabetes (T1D). The US is the largest market for the current CGMS. There are about 60 million diabetics in Europe. In 2016, Europe CGMS market accounted for $83 million and estimated to witness a CAGR of 41.72% during the forecast period. The SMBG market is accounted for $1180 million and anticipated to witness a CAGR of 10.54% during the forecast period. Asia Pacific is anticipated to be the fastest growing region in the CGMS and SMBG market. Increasing prevalence rate of diabetes in India and China are creating significant opportunities for continuous glucose monitoring system in the region. In 2015, more than 200 million people in Asia are already suffering from diabetes and the number is estimated to exceed 300 million by 2030.
COMPETETIVE INSIGHTS
Major players for the Glucose monitoring market are Dexcom, Johnson and Johnson, Tandem diabetes, Roche diagnostics, Nemaura medical Inc., Senseonics, Glysens incorporated Medtronic, Abbott, Insulet corp., and Echo therapeutics.
The global glucose monitoring system market is separated into continuous glucose monitoring market (CGMS) and self-monitoring of blood glucose (SMBG) market. The CGMS market is anticipated to grow $ 13672 million by 2025. The SMBG market is estimated to grow $ 20563 million by 2025, at a CAGR of 36.72% between 2016 and 2025. The base year considered for the market study is 2016 and the forecast period is between 2017 and 2025. The (CGM) continuous glucose monitoring device is system practiced to measure glucose levels in the interstitial fluid that commence between the skin cells and display in the monitor. (SMBG) Self-monitoring of blood glucose is to supervise glucose level.
MARKET INSIGHTS
The continuous glucose monitoring system and self-monitoring blood glucose is segmented into component type, application, and geography. The CGMS market by component type is segmented into sensors, transmitters, receivers, and insulin pump. The application segmented of CGMS is further segmented into diagnostics and clinics, hospitals, and home settings. The SMBG market by the component is segmented into test strips, glucose meter, and others. The application segmented of SMBG is further bifurcated into home settings, clinics, and hospitals. The geography market is segmented into North America, Europe, Asia-Pacific, Latin America and rest of the world. Rise in Diabetic Population, growth in Healthcare Expenditure, high Focus on Research and Development, Technology Integration, Increase in the CGMS Affordability, and less Price of Technology are the major drivers for the Glucose monitoring market.
REGIONAL INSIGHTS
The CGMS and SMBG market in North America is anticipated to hold the largest share by 2025 whereas in both CGMS and SMBG market Asia Pacific is expected to be the fastest growing region with a CAGR of 48.72% and 15.82% during the forecast period. North America is a highly developed market for CGMS and SMBG with over 3 million of Type 1 Diabetes (T1D). The US is the largest market for the current CGMS. There are about 60 million diabetics in Europe. In 2016, Europe CGMS market accounted for $83 million and estimated to witness a CAGR of 41.72% during the forecast period. The SMBG market is accounted for $1180 million and anticipated to witness a CAGR of 10.54% during the forecast period. Asia Pacific is anticipated to be the fastest growing region in the CGMS and SMBG market. Increasing prevalence rate of diabetes in India and China are creating significant opportunities for continuous glucose monitoring system in the region. In 2015, more than 200 million people in Asia are already suffering from diabetes and the number is estimated to exceed 300 million by 2030.
COMPETETIVE INSIGHTS
Major players for the Glucose monitoring market are Dexcom, Johnson and Johnson, Tandem diabetes, Roche diagnostics, Nemaura medical Inc., Senseonics, Glysens incorporated Medtronic, Abbott, Insulet corp., and Echo therapeutics.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE STUDY MARKET AND FORECASTING YEARS
1.3. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.2. BOTTOM-UP APPROACH
2.3. TOP DOWN APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY&KEY FINDINGS OF THE STUDY
4. MARKET OVERVIEW
4.1. DRIVERS AND IMPACT
4.1.1. INCREASE IN DIABETIC POPULATION
4.1.2. INCREASE IN HEALTHCARE EXPENDITURE
4.1.3. INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
4.1.4. TECHNOLOGY INTEGRATION
4.1.5. INCREASING CGMS AFFORDABILITY
4.1.6. LOW PRICE OF TECHNOLOGY
4.2. RESTRAIN AND IMPACT
4.2.1. HINDERANCE FROM GOVERNMENT REGULATIONS
4.2.2. SMBG MANUFACTURERS RESTRAINING CGMS GROWTH
5. CGMS MARKET BY COMPONENT TYPE
5.1. SENSORS
5.2. TRANSMITTERS AND RECEIVERS
5.3. INSULIN PUMP
6. CGMS MARKET BY APPLICATION
6.1. DIAGNOSTICS AND CLINICS
6.2. HOSPITALS
6.3. HOME SETTINGS
7. SMBG MARKET BY COMPONENT TYPE
7.1. TEST STRIPS
7.2. GLUCOSE METER
7.3. OTHERS
8. SMBG MARKET BY APPLICATION
8.1. HOME SETTINGS
8.2. CLINICS
8.3. HOSPITALS
9. KEY ANALYTICAL
9.1. 5 FORCES ANALYSIS
9.1.1. THREAT OF NEW ENTRANT
9.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
9.1.3. BARGAINING POWER OF BUYERS
9.1.4. BARGAINING POWER OF SUPPLIER
9.1.5. INTENSITY OF COMPETITIVE RIVALRY
9.2. TOP THREE MARKET TRENDS
9.2.1. INADEQUATE REIMBURSEMENT OPTIONS FOR CGM
9.2.2. LACK OF KNOWLEDGE
9.2.3. REDUCTION OF HANDLING EFFORTS
9.3. TOP THREE GEOGRAPHIES
9.4. MERGER AND ACQUISITIONS
9.5. KEY TRENDS
9.5.1. DEVELOPMENT OF HIGH-QUALITY WEARABLE DEVICES
9.5.2. MOBILE HEALTHCARE MAKING THE DEVICES MORE USER-FRIENDLY
9.5.3. INCREASING EFFORTS TOWARDS SPREAD OF AWARENESS
9.5.4. INCREASE IN NON-INVASIVE DEVICES
9.5.5. ENERGY HARVESTING TECHNOLOGY FOR UNINTERRUPTED USAGE
9.5.6. GLOBAL TRENDS IN ENERGY MARKET HARVESTING
10. REGIONAL ANALYSIS
10.1. NORTH AMERICA GMS MARKET
10.1.1. THE US CGMS MARKET
10.1.2. CANADA CGMS MARKET
10.2. EUROPE GMS MARKET
10.2.1. GERMANY CGMS MARKET
10.2.2. THE UK CGMS MARKET
10.2.3. FRANCE CGMS MARKET
10.2.4. REST OF EUROPE (ROE) CGMS MARKET
10.3. ASIA-PACIFIC (APAC) GMS MARKET
10.3.1. CHINA CGMS MARKET
10.3.2. INDIA CGMS MARKET
10.3.3. AUSTRALIA CGMS MARKET
10.3.4. REST OF ASIA-PACIFIC (ROAP) CGMS MARKET
10.4. LATIN AMERICACGMS MARKET
10.5. REST OF THE WORLD (ROW)GMS MARKE
11. COMPETITIVE LANDSCAPE
11.1. INTRODUCTION
11.2. MEDTRONIC
11.2.1. BUSINESS PROFILE
11.2.2. PRODUCT PORTFOLIO
11.2.3. REVENUE ANALYSIS
11.2.4. STRATEGIC INPUTS
11.2.5. SCOT ANALYSIS
11.3. DEXCOM
11.3.1. BUSINESS PROFILE
11.3.2. PRODUCT PORTFOLIO
11.3.3. REVENUE ANALYSIS
11.3.4. STRATEGIC INPUTS
11.3.5. SCOT ANALYSIS
11.4. ABBOTT
11.4.1. BUSINESS PROFILE
11.4.2. PRODUCT PORTFOLIO
11.4.3. REVENUE ANALYSIS
11.4.4. STRATEGIC INPUTS
11.4.5. SCOT ANALYSIS
11.5. JOHNSON AND JOHNSON
11.5.1. BUSINESS PROFILE
11.5.2. PRODUCT PORTFOLIO
11.5.3. REVENUE ANALYSIS
11.5.4. STRATEGIC INPUTS
11.5.5. SCOT ANALYSIS
11.6. INSULET CORP
11.6.1. BUSINESS PROFILE
11.6.2. PRODUCT PORTFOLIO
11.6.3. REVENUE ANALYSIS
11.6.4. SCOT ANALYSIS
11.7. TANDEM DIABETES
11.7.1. BUSINESS PROFILE
11.7.2. REVENUE ANALYSIS
11.7.3. PRODUCT PORTFOLIO
11.7.4. STRATEGIC INPUTS
11.7.5. SCOT ANALYSIS
11.8. ECHO THERAPEUTICS
11.8.1. BUSINESS PROFILE
11.8.2. REVENUE ANALYSIS
11.9. ROCHE DIAGNOSTICS
11.9.1. BUSINESS PROFILE
11.9.2. PRODUCT PORTFOLIO
11.9.3. REVENUE ANALYSIS
11.9.4. STRATEGIC INPUTS
11.9.5. SCOT ANALYSIS
11.10. NEMAURA MEDICAL INC.
11.10.1. BUSINESS PROFILE
11.10.2. PRODUCT PORTFOLIO
11.10.3. REVENUE ANALYSIS
11.10.4. STRATEGIC INPUTS
11.10.5. SCOT ANALYSIS
11.11. SENSEONICS
11.11.1. BUSINESS PROFILE
11.11.2. PRODUCT PORTFOLIO
11.11.3. REVENUE ANALYSIS
11.11.4. STRATEGIC INPUTS
11.11.5. SCOT ANALYSIS
11.12. GLYSENS INCORPORATED
11.12.1. BUSINESS PROFILE
11.12.2. PRODUCT PORTFOLIO
11.12.3. STRATEGIC INPUTS
11.12.4. SCOT ANALYSIS
1.1. STUDY GOALS
1.2. SCOPE OF THE STUDY MARKET AND FORECASTING YEARS
1.3. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.2. BOTTOM-UP APPROACH
2.3. TOP DOWN APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY&KEY FINDINGS OF THE STUDY
4. MARKET OVERVIEW
4.1. DRIVERS AND IMPACT
4.1.1. INCREASE IN DIABETIC POPULATION
4.1.2. INCREASE IN HEALTHCARE EXPENDITURE
4.1.3. INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
4.1.4. TECHNOLOGY INTEGRATION
4.1.5. INCREASING CGMS AFFORDABILITY
4.1.6. LOW PRICE OF TECHNOLOGY
4.2. RESTRAIN AND IMPACT
4.2.1. HINDERANCE FROM GOVERNMENT REGULATIONS
4.2.2. SMBG MANUFACTURERS RESTRAINING CGMS GROWTH
5. CGMS MARKET BY COMPONENT TYPE
5.1. SENSORS
5.2. TRANSMITTERS AND RECEIVERS
5.3. INSULIN PUMP
6. CGMS MARKET BY APPLICATION
6.1. DIAGNOSTICS AND CLINICS
6.2. HOSPITALS
6.3. HOME SETTINGS
7. SMBG MARKET BY COMPONENT TYPE
7.1. TEST STRIPS
7.2. GLUCOSE METER
7.3. OTHERS
8. SMBG MARKET BY APPLICATION
8.1. HOME SETTINGS
8.2. CLINICS
8.3. HOSPITALS
9. KEY ANALYTICAL
9.1. 5 FORCES ANALYSIS
9.1.1. THREAT OF NEW ENTRANT
9.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
9.1.3. BARGAINING POWER OF BUYERS
9.1.4. BARGAINING POWER OF SUPPLIER
9.1.5. INTENSITY OF COMPETITIVE RIVALRY
9.2. TOP THREE MARKET TRENDS
9.2.1. INADEQUATE REIMBURSEMENT OPTIONS FOR CGM
9.2.2. LACK OF KNOWLEDGE
9.2.3. REDUCTION OF HANDLING EFFORTS
9.3. TOP THREE GEOGRAPHIES
9.4. MERGER AND ACQUISITIONS
9.5. KEY TRENDS
9.5.1. DEVELOPMENT OF HIGH-QUALITY WEARABLE DEVICES
9.5.2. MOBILE HEALTHCARE MAKING THE DEVICES MORE USER-FRIENDLY
9.5.3. INCREASING EFFORTS TOWARDS SPREAD OF AWARENESS
9.5.4. INCREASE IN NON-INVASIVE DEVICES
9.5.5. ENERGY HARVESTING TECHNOLOGY FOR UNINTERRUPTED USAGE
9.5.6. GLOBAL TRENDS IN ENERGY MARKET HARVESTING
10. REGIONAL ANALYSIS
10.1. NORTH AMERICA GMS MARKET
10.1.1. THE US CGMS MARKET
10.1.2. CANADA CGMS MARKET
10.2. EUROPE GMS MARKET
10.2.1. GERMANY CGMS MARKET
10.2.2. THE UK CGMS MARKET
10.2.3. FRANCE CGMS MARKET
10.2.4. REST OF EUROPE (ROE) CGMS MARKET
10.3. ASIA-PACIFIC (APAC) GMS MARKET
10.3.1. CHINA CGMS MARKET
10.3.2. INDIA CGMS MARKET
10.3.3. AUSTRALIA CGMS MARKET
10.3.4. REST OF ASIA-PACIFIC (ROAP) CGMS MARKET
10.4. LATIN AMERICACGMS MARKET
10.5. REST OF THE WORLD (ROW)GMS MARKE
11. COMPETITIVE LANDSCAPE
11.1. INTRODUCTION
11.2. MEDTRONIC
11.2.1. BUSINESS PROFILE
11.2.2. PRODUCT PORTFOLIO
11.2.3. REVENUE ANALYSIS
11.2.4. STRATEGIC INPUTS
11.2.5. SCOT ANALYSIS
11.3. DEXCOM
11.3.1. BUSINESS PROFILE
11.3.2. PRODUCT PORTFOLIO
11.3.3. REVENUE ANALYSIS
11.3.4. STRATEGIC INPUTS
11.3.5. SCOT ANALYSIS
11.4. ABBOTT
11.4.1. BUSINESS PROFILE
11.4.2. PRODUCT PORTFOLIO
11.4.3. REVENUE ANALYSIS
11.4.4. STRATEGIC INPUTS
11.4.5. SCOT ANALYSIS
11.5. JOHNSON AND JOHNSON
11.5.1. BUSINESS PROFILE
11.5.2. PRODUCT PORTFOLIO
11.5.3. REVENUE ANALYSIS
11.5.4. STRATEGIC INPUTS
11.5.5. SCOT ANALYSIS
11.6. INSULET CORP
11.6.1. BUSINESS PROFILE
11.6.2. PRODUCT PORTFOLIO
11.6.3. REVENUE ANALYSIS
11.6.4. SCOT ANALYSIS
11.7. TANDEM DIABETES
11.7.1. BUSINESS PROFILE
11.7.2. REVENUE ANALYSIS
11.7.3. PRODUCT PORTFOLIO
11.7.4. STRATEGIC INPUTS
11.7.5. SCOT ANALYSIS
11.8. ECHO THERAPEUTICS
11.8.1. BUSINESS PROFILE
11.8.2. REVENUE ANALYSIS
11.9. ROCHE DIAGNOSTICS
11.9.1. BUSINESS PROFILE
11.9.2. PRODUCT PORTFOLIO
11.9.3. REVENUE ANALYSIS
11.9.4. STRATEGIC INPUTS
11.9.5. SCOT ANALYSIS
11.10. NEMAURA MEDICAL INC.
11.10.1. BUSINESS PROFILE
11.10.2. PRODUCT PORTFOLIO
11.10.3. REVENUE ANALYSIS
11.10.4. STRATEGIC INPUTS
11.10.5. SCOT ANALYSIS
11.11. SENSEONICS
11.11.1. BUSINESS PROFILE
11.11.2. PRODUCT PORTFOLIO
11.11.3. REVENUE ANALYSIS
11.11.4. STRATEGIC INPUTS
11.11.5. SCOT ANALYSIS
11.12. GLYSENS INCORPORATED
11.12.1. BUSINESS PROFILE
11.12.2. PRODUCT PORTFOLIO
11.12.3. STRATEGIC INPUTS
11.12.4. SCOT ANALYSIS
LIST OF TABLES
TABLE 1 GLOBAL SMBG MARKET BY GEOGRAPHY, 2017-2025 (IN US$ MILLION)
TABLE 2 GLOBAL CGMS MARKET BY GEOGRAPHY, 2017-2025 (IN US$ MILLION)
TABLE 3 GLOBAL CGMS MARKET, BY COMPONENT TYPE, 2017-2025 (IN US$ MILLION)
TABLE 4 GLOBAL CGMS SENSORS MARKET, 2017-2025 (IN US$ MILLION)
TABLE 5 GLOBAL CGMS TRANSMITTERS AND RECEIVERS MARKET, 2017-2025 (IN US$ MILLION)
TABLE 6 GLOBAL CGMS INSULIN PUMP MARKET, 2017-2025 (IN US$ MILLION)
TABLE 7 GLOBAL CGMS MARKET, BY APPLICATION 2017 – 2025 (IN US$ MILLION)
TABLE 8 GLOBAL SMBG MARKET, BY COMPONENT TYPE, 2017-2025 (IN US$ MILLION)
TABLE 9 GLOBAL SMBG MARKET REVENUE, BY REGION, 2017-2025 (IN US$ MILLION)
TABLE 10 GLOBAL CGMS MARKET REVENUE, BY REGION, 2017-2025 (IN US$ MILLION)
TABLE 11 GERMANY DIABETIC STATISTICS 2016
TABLE 1 GLOBAL SMBG MARKET BY GEOGRAPHY, 2017-2025 (IN US$ MILLION)
TABLE 2 GLOBAL CGMS MARKET BY GEOGRAPHY, 2017-2025 (IN US$ MILLION)
TABLE 3 GLOBAL CGMS MARKET, BY COMPONENT TYPE, 2017-2025 (IN US$ MILLION)
TABLE 4 GLOBAL CGMS SENSORS MARKET, 2017-2025 (IN US$ MILLION)
TABLE 5 GLOBAL CGMS TRANSMITTERS AND RECEIVERS MARKET, 2017-2025 (IN US$ MILLION)
TABLE 6 GLOBAL CGMS INSULIN PUMP MARKET, 2017-2025 (IN US$ MILLION)
TABLE 7 GLOBAL CGMS MARKET, BY APPLICATION 2017 – 2025 (IN US$ MILLION)
TABLE 8 GLOBAL SMBG MARKET, BY COMPONENT TYPE, 2017-2025 (IN US$ MILLION)
TABLE 9 GLOBAL SMBG MARKET REVENUE, BY REGION, 2017-2025 (IN US$ MILLION)
TABLE 10 GLOBAL CGMS MARKET REVENUE, BY REGION, 2017-2025 (IN US$ MILLION)
TABLE 11 GERMANY DIABETIC STATISTICS 2016
LIST OF FIGURES
FIGURE 1 GLOBAL CGMS MARKET SHARE, BY COMPONENT TYPE 2016 & 2025 (%)
FIGURE 2 GLOBAL CGMS SENSORS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 3 GLOBAL CGMS TRANSMITTERS AND RECEIVERS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 4 GLOBAL CGMS INSULIN PUMP MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 5 GLOBAL CGMS SHARE, BY APPLICATION 2016 & 2025 (%)
FIGURE 6 GLOBAL CGMS DIAGNOSTICS AND CLINICAL MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 7 GLOBAL CGMS HOSPITALS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 8 GLOBAL CGMS HOME SETTING MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 9 GLOBAL SMBG MARKET SHARE, BY COMPONENT TYPE 2016 & 2025 (%)
FIGURE 10 GLOBAL SMBG TEST STRIPS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 11 GLOBAL SMBG GLUCOSE METER MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 12 GLOBAL SMBG OTHERS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 13 GLOBAL SMBG MARKET SHARE, BY COMPONENT TYPE 2016 & 2025 (%)
FIGURE 14 GLOBAL SMBG HOME SETTING MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 15 GLOBAL SMBG DIAGNOSTICS AND CLINICAL MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 16 GLOBAL SMBG HOSPITALS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 17 TOP THREE GEOGRAPHIES 2016
FIGURE 18 GLOBAL SMBG MARKET SHARE, BY GEOGRAPHY 2016 & 2025 (%)
FIGURE 19 GLOBAL GGMS MARKET SHARE, BY GEOGRAPHY 2016 & 2025 (%)
FIGURE 20 NORTH AMERICA SMBG MARKET REVENUE 2017-2025 (US$ MILLION)
FIGURE 21 NORTH AMERICA CGMS MARKET SHARE, BY COUNTRY 2016 & 2025 (%)
FIGURE 22 US CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 23 CANADA CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 24 EUROPE SMBG MARKET REVENUE 2017-2025 (US$ MILLION)
FIGURE 25 EUROPE CGM MARKET SHARE, BY COUNTRY 2016 & 2025 (%)
FIGURE 26 GERMANY CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 27 UK CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 28 FRANCE CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 29 REST OF EUROPE (ROE) CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 30 ASIA-PACIFIC SMBG MARKET REVENUE 2017-2025 (US$ MILLION)
FIGURE 31 ASIA-PACIFIC CGM MARKET SHARE, BY COUNTRY 2016 & 2025 (%)
FIGURE 32 CHINA CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 33 INDIA CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 34 AUSTRALIA CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 35 ROAP CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 36 LATIN AMERICA SMBG MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 37 LATIN AMERICA CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 38 ROW SMBG MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 39 ROW CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 1 GLOBAL CGMS MARKET SHARE, BY COMPONENT TYPE 2016 & 2025 (%)
FIGURE 2 GLOBAL CGMS SENSORS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 3 GLOBAL CGMS TRANSMITTERS AND RECEIVERS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 4 GLOBAL CGMS INSULIN PUMP MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 5 GLOBAL CGMS SHARE, BY APPLICATION 2016 & 2025 (%)
FIGURE 6 GLOBAL CGMS DIAGNOSTICS AND CLINICAL MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 7 GLOBAL CGMS HOSPITALS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 8 GLOBAL CGMS HOME SETTING MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 9 GLOBAL SMBG MARKET SHARE, BY COMPONENT TYPE 2016 & 2025 (%)
FIGURE 10 GLOBAL SMBG TEST STRIPS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 11 GLOBAL SMBG GLUCOSE METER MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 12 GLOBAL SMBG OTHERS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 13 GLOBAL SMBG MARKET SHARE, BY COMPONENT TYPE 2016 & 2025 (%)
FIGURE 14 GLOBAL SMBG HOME SETTING MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 15 GLOBAL SMBG DIAGNOSTICS AND CLINICAL MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 16 GLOBAL SMBG HOSPITALS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 17 TOP THREE GEOGRAPHIES 2016
FIGURE 18 GLOBAL SMBG MARKET SHARE, BY GEOGRAPHY 2016 & 2025 (%)
FIGURE 19 GLOBAL GGMS MARKET SHARE, BY GEOGRAPHY 2016 & 2025 (%)
FIGURE 20 NORTH AMERICA SMBG MARKET REVENUE 2017-2025 (US$ MILLION)
FIGURE 21 NORTH AMERICA CGMS MARKET SHARE, BY COUNTRY 2016 & 2025 (%)
FIGURE 22 US CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 23 CANADA CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 24 EUROPE SMBG MARKET REVENUE 2017-2025 (US$ MILLION)
FIGURE 25 EUROPE CGM MARKET SHARE, BY COUNTRY 2016 & 2025 (%)
FIGURE 26 GERMANY CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 27 UK CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 28 FRANCE CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 29 REST OF EUROPE (ROE) CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 30 ASIA-PACIFIC SMBG MARKET REVENUE 2017-2025 (US$ MILLION)
FIGURE 31 ASIA-PACIFIC CGM MARKET SHARE, BY COUNTRY 2016 & 2025 (%)
FIGURE 32 CHINA CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 33 INDIA CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 34 AUSTRALIA CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 35 ROAP CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 36 LATIN AMERICA SMBG MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 37 LATIN AMERICA CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 38 ROW SMBG MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 39 ROW CGM MARKET REVENUE, 2017-2025 (IN USD MILLION)
